ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
investment factor · long-only model fund

Foundry DelCOL Industry-Neutral Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FDERHYPOTHETICAL MODEL
Since ’99
−74%
Expense Ratio
0.35%
placeholder
Holdings
226
cap-weighted
Inception
Apr 2022
placeholder
Full Sharpe
-0.21
Ann. Return (LS)
-3.5%
Ann. Volatility
16.3%
Max Drawdown
-81.1%
Test Sharpe ’19–26
-0.37
Test FF5 α (ann.)
-8.5%
vs Fama-French 5
Test FF5 α t-stat
-1.36
not significant
Monthly turnover
25%
of the long leg, per rebalance
Cumulative return (LS)
-74%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.62
what this fund holds
Long leg ann. return
10.6%
buyable, long-only
Long-short Sharpe
-0.21
requires shorting
Bottom bucket ann. return
14.1%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

226 of 226 · 100.0% of book
TickerCompanySectorMarket capWeight
1AAPL
APPLE INCTechnology$4.90T
66.64%
2CSCO
CISCO SYSTEMS INCTechnology$441.20B
6.00%
3UNH
UNITEDHEALTH GROUP INCHealthcare$386.95B
5.26%
4DIS
WALT DISNEY COCommunication Services$169.61B
2.31%
5BMY
BRISTOL MYERS SQUIBB COHealthcare$124.04B
1.69%
6MDT
MEDTRONIC PLCHealthcare$106.50B
1.45%
7MRSH
MARSH & MCLENNAN COMPANIES INCFinancial Services$87.77B
1.19%
8AON
AON PLCFinancial Services$78.43B
1.07%
9CI
CIGNA GROUPHealthcare$74.45B
1.01%
10CARR
CARRIER GLOBAL CORPBasic Materials$57.05B
0.78%
11NDAQ
NASDAQ INCFinancial Services$51.83B
0.70%
12EW
EDWARDS LIFESCIENCES CORPHealthcare$49.36B
0.67%
13GRMN
GARMIN LTDTechnology$48.13B
0.65%
14BDX
BECTON DICKINSON & COHealthcare$43.58B
0.59%
15MSTR
STRATEGY INCTechnology$33.24B
0.45%
16UI
UBIQUITI INCTechnology$33.04B
0.45%
17NTAP
NETAPP INCTechnology$32.11B
0.44%
18DLTR
DOLLAR TREE INCConsumer Defensive$24.20B
0.33%
19FSLR
FIRST SOLAR INCTechnology$22.78B
0.31%
20ROL
ROLLINS INCConsumer Cyclical$21.72B
0.30%
21LII
LENNOX INTERNATIONAL INCBasic Materials$18.93B
0.26%
22FTV
FORTIVE CORPTechnology$18.83B
0.26%
23ZBH
ZIMMER BIOMET HOLDINGS INCHealthcare$17.63B
0.24%
24APG
API GROUP CORPIndustrials$17.38B
0.24%
25NWSA
NEWS CORPCommunication Services$15.56B
0.21%
26DECK
DECKERS OUTDOOR CORPConsumer Cyclical$14.79B
0.20%
27SITM
SITIME CORPTechnology$14.65B
0.20%
28SWK
STANLEY BLACK & DECKER INCIndustrials$14.02B
0.19%
29LDOS
LEIDOS HOLDINGS INCTechnology$13.39B
0.18%
30ALGN
ALIGN TECHNOLOGY INCHealthcare$12.66B
0.17%
31DKNG
DRAFTKINGS INCConsumer Cyclical$12.37B
0.17%
32W
WAYFAIR INCConsumer Cyclical$11.79B
0.16%
33CLX
CLOROX COConsumer Defensive$11.65B
0.16%
34VICR
VICOR CORPTechnology$10.83B
0.15%
35JKHY
JACK HENRY & ASSOCIATES INCTechnology$10.78B
0.15%
36HUT
HUT 8 CORPFinancial Services$10.30B
0.14%
37MSGS
MADISON SQUARE GARDEN SPORTS CORPCommunication Services$9.56B
0.13%
38BMNR
BITMINE IMMERSION TECHNOLOGIES INCFinancial Services$9.46B
0.13%
39LTH
LIFE TIME GROUP HOLDINGS INCConsumer Cyclical$9.38B
0.13%
40CHYM
CHIME FINANCIAL INCTechnology$8.51B
0.12%
41GOLF
ACUSHNET HOLDINGS CORPConsumer Cyclical$6.72B
0.09%
42SWX
SOUTHWEST GAS HOLDINGS INCUtilities$6.66B
0.09%
43VFC
V F CORPConsumer Cyclical$6.65B
0.09%
44NE
NOBLE CORP PLCEnergy$6.62B
0.09%
45RYN
RAYONIER INCReal Estate$6.56B
0.09%
46MXL
MAXLINEAR INCTechnology$6.43B
0.09%
47IBP
INSTALLED BUILDING PRODUCTS INCConsumer Cyclical$6.16B
0.08%
48FBIN
FORTUNE BRANDS INNOVATIONS INCBasic Materials$6.14B
0.08%
49PSN
PARSONS CORPTechnology$6.00B
0.08%
50TFX
TELEFLEX INCHealthcare$5.96B
0.08%
51ROAD
CONSTRUCTION PARTNERS INCIndustrials$5.91B
0.08%
52CHDN
CHURCHILL DOWNS INCConsumer Cyclical$5.85B
0.08%
53BLCO
BAUSCH & LOMB CORPHealthcare$5.80B
0.08%
54OTEX
OPEN TEXT CORPTechnology$5.65B
0.08%
55MTN
VAIL RESORTS INCConsumer Cyclical$5.27B
0.07%
56SPHR
SPHERE ENTERTAINMENT COCommunication Services$5.10B
0.07%
57SAIC
SCIENCE APPLICATIONS INTERNATIONAL CORPTechnology$4.88B
0.07%
58CNX
CNX RESOURCES CORPEnergy$4.71B
0.06%
59PRIM
PRIMORIS SERVICES CORPIndustrials$4.66B
0.06%
60KBR
KBR INCIndustrials$4.45B
0.06%
61MMSI
MERIT MEDICAL SYSTEMS INCHealthcare$4.41B
0.06%
62NVST
ENVISTA HOLDINGS CORPHealthcare$4.35B
0.06%
63WAY
WAYSTAR HOLDING CORPHealthcare$4.27B
0.06%
64DORM
DORMAN PRODUCTS INCConsumer Cyclical$4.24B
0.06%
65GPGI
GPGI INCIndustrials$4.21B
0.06%
66PLNT
PLANET FITNESS INCConsumer Cyclical$4.16B
0.06%
67TNGX
TANGO THERAPEUTICS INCHealthcare$4.13B
0.06%
68ICUI
ICU MEDICAL INCHealthcare$3.94B
0.05%
69IRTC
IRHYTHM HOLDINGS INCHealthcare$3.64B
0.05%
70BATRA
ATLANTA BRAVES HOLDINGS INCCommunication Services$3.63B
0.05%
71CNK
CINEMARK HOLDINGS INCCommunication Services$3.55B
0.05%
72HAE
HAEMONETICS CORPHealthcare$3.54B
0.05%
73CVI
CVR ENERGY INCEnergy$3.53B
0.05%
74NATL
NCR ATLEOS CORPTechnology$3.50B
0.05%
75CALY
CALLAWAY GOLF COConsumer Cyclical$3.48B
0.05%
76XXI
TWENTY ONE CAPITAL INCIndustrials$3.48B
0.05%
77HP
HELMERICH & PAYNE INCEnergy$3.41B
0.05%
78CLSK
CLEANSPARK INCFinancial Services$3.34B
0.05%
79BSM
BLACK STONE MINERALS LPEnergy$3.25B
0.04%
80AAP
ADVANCE AUTO PARTS INCConsumer Cyclical$3.19B
0.04%
81EEFT
EURONET WORLDWIDE INCTechnology$3.10B
0.04%
82LEU
CENTRUS ENERGY CORPBasic Materials$3.07B
0.04%
83AD
ARRAY DIGITAL INFRASTRUCTURE INCCommunication Services$3.02B
0.04%
84DAN
DANA INCConsumer Cyclical$2.87B
0.04%
85BEAM
BEAM THERAPEUTICS INCHealthcare$2.83B
0.04%
86SMR
NUSCALE POWER CORPIndustrials$2.82B
0.04%
87XRAY
DENTSPLY SIRONA INCHealthcare$2.81B
0.04%
88WTTR
SELECT WATER SOLUTIONS INCBasic Materials$2.81B
0.04%
89TNET
TRINET GROUP INCIndustrials$2.74B
0.04%
90VISN
VISTANCE NETWORKS INCTechnology$2.74B
0.04%
91OSW
ONESPAWORLD HOLDINGS LTDConsumer Cyclical$2.68B
0.04%
92AEHR
AEHR TEST SYSTEMSTechnology$2.55B
0.03%
93PBI
PITNEY BOWES INCIndustrials$2.51B
0.03%
94PLUS
EPLUS INCTechnology$2.33B
0.03%
95BHVN
BIOHAVEN LTDHealthcare$2.32B
0.03%
96AGL
AGILON HEALTH INCHealthcare$2.17B
0.03%
97PRKS
UNITED PARKS & RESORTS INCConsumer Cyclical$2.13B
0.03%
98CPRI
CAPRI HOLDINGS LTDConsumer Cyclical$1.89B
0.03%
99UFPT
UFP TECHNOLOGIES INCHealthcare$1.87B
0.03%
100ZYME
ZYMEWORKS INCHealthcare$1.77B
0.02%
101PLPC
PREFORMED LINE PRODUCTS COIndustrials$1.60B
0.02%
102VIR
VIR BIOTECHNOLOGY INCHealthcare$1.59B
0.02%
103IART
INTEGRA LIFESCIENCES HOLDINGS CORPHealthcare$1.50B
0.02%
104BLKB
BLACKBAUD INCTechnology$1.49B
0.02%
105BLFS
BIOLIFE SOLUTIONS INCHealthcare$1.42B
0.02%
106HLX
HELIX ENERGY SOLUTIONS GROUP INCEnergy$1.41B
0.02%
107FMC
FMC CORPBasic Materials$1.40B
0.02%
108AI
C3AI INCTechnology$1.37B
0.02%
109NVAX
NOVAVAX INCHealthcare$1.35B
0.02%
110FBYD
FALCON'S BEYOND GLOBAL INCIndustrials$1.35B
0.02%
111STAA
STAAR SURGICAL COHealthcare$1.32B
0.02%
112CNMD
CONMED CORPHealthcare$1.30B
0.02%
113ABSI
ABSCI CORPHealthcare$1.29B
0.02%
114INBX
INHIBRX BIOSCIENCES INCHealthcare$1.28B
0.02%
115NBR
NABORS INDUSTRIES LTDEnergy$1.24B
0.02%
116CMP
COMPASS MINERALS INTERNATIONAL INCBasic Materials$1.24B
0.02%
117TNDM
TANDEM DIABETES CARE INCHealthcare$1.17B
0.02%
118AVNS
AVANOS MEDICAL INCHealthcare$1.17B
0.02%
119VYX
NCR VOYIX CORPTechnology$1.13B
0.02%
120CRTO
CRITEO SACommunication Services$1.13B
0.02%
121WVE
WAVE LIFE SCIENCES LTDHealthcare$1.12B
0.02%
122CRSR
CORSAIR GAMING INCTechnology$1.04B
0.01%
123LUCK
LUCKY STRIKE ENTERTAINMENT CORPConsumer Cyclical$1.01B
0.01%
124BVS
BIOVENTUS INCHealthcare$1.01B
0.01%
125ACEL
ACCEL ENTERTAINMENT INCConsumer Cyclical$989M
0.01%
126LMB
LIMBACH HOLDINGS INCIndustrials$867M
0.01%
127MATW
MATTHEWS INTERNATIONAL CORPIndustrials$857M
0.01%
128AVR
ANTERIS TECHNOLOGIES GLOBAL CORPHealthcare$823M
0.01%
129WLKP
WESTLAKE CHEMICAL PARTNERS LPBasic Materials$776M
0.01%
130SIBN
SI-BONE INCHealthcare$771M
0.01%
131MCS
MARCUS CORPCommunication Services$708M
0.01%
132PSIX
POWER SOLUTIONS INTERNATIONAL INCIndustrials$697M
0.01%
133PKE
PARK AEROSPACE CORPIndustrials$677M
0.01%
134PAR
PAR TECHNOLOGY CORPTechnology$674M
0.01%
135RSVR
RESERVOIR MEDIA INCCommunication Services$671M
0.01%
136MNTN
MNTN INCTechnology$661M
0.01%
137EVH
EVOLENT HEALTH INCHealthcare$654M
0.01%
138HY
HYSTER-YALE INCIndustrials$591M
0.01%
139ALIT
ALIGHT INCTechnology$584M
0.01%
140STTK
SHATTUCK LABS INCHealthcare$577M
0.01%
141ANGO
ANGIODYNAMICS INCHealthcare$558M
0.01%
142XMAX
XMAX INCConsumer Cyclical$541M
0.01%
143YEXT
YEXT INCTechnology$535M
0.01%
144BBCP
CONCRETE PUMPING HOLDINGS INCIndustrials$531M
0.01%
145ORN
ORION GROUP HOLDINGS INCIndustrials$518M
0.01%
146ZURA
ZURA BIO LTDHealthcare$518M
0.01%
147ARVN
ARVINAS INCHealthcare$517M
0.01%
148PRTA
PROTHENA CORP PUBLIC LTD COHealthcare$453M
0.01%
149STRZ
STARZ ENTERTAINMENT CORPCommunication Services$450M
0.01%
150TITN
TITAN MACHINERY INCIndustrials$446M
0.01%
151BNED
BARNES & NOBLE EDUCATION INCConsumer Cyclical$437M
0.01%
152CCRN
CROSS COUNTRY HEALTHCARE INCHealthcare$428M
0.01%
153ASMB
ASSEMBLY BIOSCIENCES INCHealthcare$426M
0.01%
154QMCO
QUANTUM CORPTechnology$419M
0.01%
155CLFD
CLEARFIELD INCTechnology$416M
0.01%
156IMXI
INTERNATIONAL MONEY EXPRESS INCTechnology$404M
0.01%
157CCIX
CHURCHILL CAPITAL CORP IXIndustrials$398M
0.01%
158STRO
SUTRO BIOPHARMA INCHealthcare$391M
0.01%
159VALU
VALUE LINE INCFinancial Services$385M
0.01%
160BBBY
BED BATH & BEYOND INCConsumer Cyclical$372M
0.01%
161ZNTL
ZENTALIS PHARMACEUTICALS INCHealthcare$364M
0.00%
162SDHI
SIDDHI ACQUISITION CORP (CAYMAN ISLANDS)Industrials$364M
0.00%
163MTRX
MATRIX SERVICE COIndustrials$342M
0.00%
164XPOF
XPONENTIAL FITNESS INCConsumer Cyclical$328M
0.00%
165BKKT
BAKKT INCTechnology$323M
0.00%
166VELO
VELO3D INCTechnology$316M
0.00%
167MKTW
MARKETWISE INCTechnology$314M
0.00%
168OSS
ONE STOP SYSTEMS INCTechnology$313M
0.00%
169BKTI
BK TECHNOLOGIES CORPTechnology$307M
0.00%
170PNRG
PRIMEENERGY RESOURCES CORPEnergy$302M
0.00%
171TSSI
TSS INCTechnology$274M
0.00%
172AVNW
AVIAT NETWORKS INCTechnology$269M
0.00%
173ZSQR
Z SQUARED INCHealthcare$260M
0.00%
174SVCO
SILVACO GROUP INCTechnology$260M
0.00%
175TBCH
TURTLE BEACH CORPTechnology$258M
0.00%
176CLW
CLEARWATER PAPER CORPBasic Materials$258M
0.00%
177QTTB
Q32 BIO INCHealthcare$255M
0.00%
178UP
WHEELS UP EXPERIENCE INCIndustrials$229M
0.00%
179UTMD
UTAH MEDICAL PRODUCTS INCHealthcare$222M
0.00%
180ALOT
ASTRONOVA INCTechnology$222M
0.00%
181KROS
KEROS THERAPEUTICS INCHealthcare$211M
0.00%
182AGEN
AGENUS INCHealthcare$209M
0.00%
183DTIL
PRECISION BIOSCIENCES INCHealthcare$203M
0.00%
184AMWL
AMERICAN WELL CORPHealthcare$199M
0.00%
185DERM
JOURNEY MEDICAL CORPHealthcare$197M
0.00%
186EGAN
EGAIN CORPTechnology$180M
0.00%
187INGN
INOGEN INCHealthcare$178M
0.00%
188TAYD
TAYLOR DEVICES INCIndustrials$176M
0.00%
189INSE
INSPIRED ENTERTAINMENT INCConsumer Cyclical$174M
0.00%
190ARCT
ARCTURUS THERAPEUTICS HOLDINGS INCHealthcare$172M
0.00%
191CHCI
COMSTOCK HOLDING COMPANIES INCReal Estate$162M
0.00%
192RCEL
AVITA MEDICAL INCHealthcare$157M
0.00%
193EML
EASTERN COIndustrials$154M
0.00%
194WW
WW INTERNATIONAL INCConsumer Cyclical$146M
0.00%
195RAIL
FREIGHTCAR AMERICA INCIndustrials$144M
0.00%
196ACNT
ASCENT INDUSTRIES COBasic Materials$138M
0.00%
197DMRC
DIGIMARC CORPTechnology$133M
0.00%
198JYNT
JOINT CORPHealthcare$127M
0.00%
199CUE
CUE BIOPHARMA INCHealthcare$126M
0.00%
200OPRX
OPTIMIZERX CORPHealthcare$126M
0.00%
201SPRB
SPRUCE BIOSCIENCES INCHealthcare$120M
0.00%
202MED
MEDIFAST INCConsumer Cyclical$114M
0.00%
203KEQU
KEWAUNEE SCIENTIFIC CORPConsumer Cyclical$109M
0.00%
204MHH
MASTECH DIGITAL INCIndustrials$89M
0.00%
205CSBR
CHAMPIONS ONCOLOGY INCHealthcare$85M
0.00%
206FVN
FUTURE VISION II ACQUISITION CORPIndustrials$83M
0.00%
207CPHC
CANTERBURY PARK HOLDING CORPConsumer Cyclical$82M
0.00%
208BARK
BARK INCConsumer Cyclical$82M
0.00%
209DLHC
DLH HOLDINGS CORPIndustrials$80M
0.00%
210LFVN
LIFEVANTAGE CORPConsumer Defensive$78M
0.00%
211SEAT
VIVID SEATS INCCommunication Services$78M
0.00%
212ROLR
HIGH ROLLER TECHNOLOGIES INCConsumer Cyclical$76M
0.00%
213ATRA
ATARA BIOTHERAPEUTICS INCHealthcare$76M
0.00%
214BNAI
BRAND ENGAGEMENT NETWORK INCTechnology$76M
0.00%
215CLNN
CLENE INCHealthcare$76M
0.00%
216BODI
BEACHBODY COMPANY INCCommunication Services$75M
0.00%
217TISI
TEAM INCIndustrials$75M
0.00%
218AGPU
AXE COMPUTE INCHealthcare$72M
0.00%
219LNSR
LENSAR INCHealthcare$70M
0.00%
220BGSF
BGSF INCIndustrials$65M
0.00%
221STEM
STEM INCTechnology$56M
0.00%
222SNWV
SANUWAVE HEALTH INCHealthcare$55M
0.00%
223TACT
TRANSACT TECHNOLOGIES INCTechnology$54M
0.00%
224XLO
XILIO THERAPEUTICS INCHealthcare$53M
0.00%
225MCRB
SERES THERAPEUTICS INCHealthcare$52M
0.00%
226ACFN
ACORN ENERGY INCTechnology$51M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $7.36T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

11 sectors
Technology
76.7%
Healthcare
12.2%
Financial Services
3.3%
Communication Services
2.9%
Consumer Cyclical
1.8%
Basic Materials
1.2%
Industrials
1.0%
Consumer Defensive
0.5%
Energy
0.3%
Real Estate
0.1%
Utilities
0.1%

Portfolio Style

Size × value map of the long-leg book

226 classified
Value
Blend
Growth
Large
Mid
Small
7%12
13%20
77%19
1%21
1%21
1%25
<1%33
<1%32
<1%16

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 98% toward Large, 86% toward Growth. +1% unclassified (27 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt98% → Large
SmallLarge
Value ↔ growth tilt86% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 226 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
1
Failed
4
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.

    Required
    >= 75.0%
    Actual
    37.1%
    Margin
    -37.9%
  • No more than 25% of total assets may be invested in the securities of any one issuer.

    Required
    <= 25.0%
    Actual
    66.6%
    Margin
    -41.6%
  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    73.9%
    Margin
    -48.9%
  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied
  • At least 50% of total assets must sit in cash, government securities, other RICs, and other securities limited to 5% of assets and 10% of the issuer's voting securities per issuer.

    Required
    >= 50.0%
    Actual
    37.1%
    Margin
    -12.9%

    Arithmetically entailed by '40 Act 5(b)(1) diversification (75%/5% asset leg) — it cannot fail independently, so it is reported outside the tally rather than counted as a separate check.

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 226 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.1 (95% CI 0.7-1.2)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
10.3%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.07x
within
parametric
1.07x
within
cornish fisher
0.94x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2005
Before publication (pre-2005)
0.03
Sharpe · 0.5% p.a.
January 1999December 2005 · 84 mo
Since publication
-0.31
Sharpe · -4.8% p.a.
January 2006July 2026 · 247 mo
Change in Sharpe−0.34the return reversed sign — the published edge now runs the other way

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
35%
9 of 26 3-year windows made money
Worst window
-1.66
Sharpe, January 2018 – December 2020
January 1999July 2026
Median Sharpe
-0.15
Dispersion
0.60
Best window
0.79

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.23.3%12.5%
3 yearsp.a.20.6%-7.3%
5 yearsp.a.13.5%-1.9%
10 yearsp.a.10.8%-11.0%
Since inceptionp.a.9.5%-4.7%
Calendar years
YearLong legLong-short
20267 mo25.3%20.5%
20257.6%-16.3%
202426.1%-17.2%
202316.7%-21.9%
2022-5.6%46.8%
20217.5%-19.3%
202011.0%-30.4%
201918.6%-6.4%
2018-13.5%-27.7%
201720.7%-14.9%
201613.2%5.4%
20156.0%-13.7%
201418.4%12.0%
201339.0%-2.7%
201211.1%-16.5%
201114.0%9.8%
201021.9%1.6%
200932.1%-18.9%
2008-29.1%23.8%
200718.3%-9.2%
200623.7%10.1%
20055.5%2.2%
200415.4%-12.5%
200336.3%3.7%
2002-27.7%-6.3%
20015.0%45.5%
2000-24.9%2.7%
199912.7%-29.3%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FDER
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.35% (placeholder)
Inception2022-04-19 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$7.36T

Methodology

The Foundry DelCOL Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a DelCOL signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.